Advanced Bio-Technologies, Inc. ("ABT") is poised to become one of the world leaders in the global scar treatment market, with patented formulas that have become the "Gold Standard" for scar management. ABT's flagship product, Kelo-cote® Advanced Formula Scar Gel, is a proprietary silicone technology used to treat and prevent abnormal scarring such as keloid, burn and hypertrophic scars. The product is able to flatten raised scars, decrease itching and reduce discoloration and redness. ABT serves the world's lucrative plastic surgery (preventative and post surgical) market which is estimated to be growing at 30% per annum, with over 11.7 million procedures conducted in 2004 in the US alone1.
ABT's mission is to become a Global leader in the scar treatment market with a focus on quality throughout the organization to ensure the marketing and development of effective products that set the standard of care.
ABT recently obtained FDA approval for the first silicone scar treatment available in a spray which has exciting applications in burn scar treatment and widespread hypertrophic scars. This product approval demonstrates ABT's determination in introducing state of the art advanced products that will set the standard of care.
ABT's dedication to quality is demonstrated through a strong clinical program that provides clinical evidence of efficacy to support our products, and establishes ABT as a serious medical company.
